1.
Apolipoprotein L-I is the trypanosome lytic factor of human serum
by Pays, Etienne
Nature (London), 2003, Vol.422 (6927), p.83-87
2.
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?
by Rader, Daniel J
Nature medicine, 2012, Vol.18 (9), p.1344-1346
3.
The Association Between Air Pollution Exposure and Glucose and Lipids Levels
by Yitshak Sade, Maayan
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (6), p.2460-2467
4.
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
by Gabay, Cem Cem
Annals of the rheumatic diseases, 2015, Vol.75 (10), p.1806-1812
5.
Role of MicroRNAs in Cholesterol Efflux and Hepatic Lipid Metabolism
by Moore, Kathryn J
Annual review of nutrition, 2011, Vol.31 (1), p.49-63
6.
The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk?
by Heinecke, Jay W
Nature medicine, 2012, Vol.18 (9), p.1346-1347
7.
Changes in Lipoprotein Kinetics Associated With Type 2 Diabetes Affect the Distribution of Lipopolysaccharides Among Lipoproteins
by Vergès, Bruno
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (7), p.E1245-E1253
8.
Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis
by O'Neill, Francis Francis
Heart (British Cardiac Society), 2016, Vol.103 (10), p.766-773
9.
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
by Harbaum, Lars
Thorax, 2019, Vol.74 (4), p.380-389
10.
Sex Differences in Biomarkers Associated With Insulin Resistance in Obese Adolescents: Metabolomic Profiling and Principal Components Analysis
by Newbern, Dorothee
The journal of clinical endocrinology and metabolism, 2014, Vol.99 (12), p.4730-4739
11.
Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery
by Sell, Henrike
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (6), p.2892-2896
12.
Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis
by Li, Na
Clinical rheumatology, 2022, Vol.41 (3), p.677-688
13.
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
by Ooi, Esther M. M
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (10), p.E1568-E1576
14.
Copeptin predicts coronary artery disease cardiovascular and total mortality
by Tasevska, Irina
Heart (British Cardiac Society), 2016, Vol.102 (2), p.127-132
15.
Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis
by Lekkou, Alexandra, PhD
Journal of critical care, 2014, Vol.29 (5), p.723-727
16.
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins
by Fazio, Sergio
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (9), p.3340-3348
17.
Walk-Run Training Improves the Anti-Inflammation Properties of High-Density Lipoprotein in Patients With Metabolic Syndrome
by Sang, Hui
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (3), p.870-879
18.
Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance
by Scheuer, Stine H
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (9), p.3340-3347
19.
High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis
by Charles-Schoeman, Christina
Clinical rheumatology, 2017, Vol.37 (3), p.615-622
20.
NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non‐HDL‐C levels
by Corey, K. E.
Alimentary pharmacology & therapeutics, 2015, Vol.41 (3), p.301-309
